SlideShare a Scribd company logo
1 of 49
Download to read offline
By
Dr. Jitendra Wadhwani
PG ORTHOPAEDICS
PGIMS, ROHTAK
 Zenker, a pathologist,1st identified fat embolism
syndrome at autopsy 1862.
 First diagnosed in 1873 by Dr Von Bergmann
 1879 Fenger and Salisbury published description of
FES
Fat Emboli: Fat particles or droplets
that travel through the circulation
Fat Embolism: A process by which fat
emboli passes into the bloodstream
and lodges within a blood vessel.
Fat Embolism Syndrome (FES):
serious manifestation of fat
embolism occasionally causes multi
system dysfunction, the lungs are
always involved and next is brain
FAT EMBOLISM SYNDROME:
 Clinical diagnosis, No specific laboratory test is
diagnostic
 Mostly associated with long bone and pelvic #, and
more frequent in closed # then open #
 Single long bone fracture 1-5% chance of
developing FES, and increases with number of #
 Onset is 24-72 hours from initial insult
 Mortality: 5-15%
Fat embolism
Fat embolism
CAUSES CONTD..
 Blunt Trauma (90%)
CAUSES CONTD..
 Non Trauma: agglutination of chylomicrons and VLDL
by high levels of plasma CRP.
– disease-related
• Diabetes, acute pancreatitis, burns, SLE, sickle cell crisis
– drug-related
• parenteral lipid infusion
– procedure-related
• Orthopedic surgery, liposuction
Exact mechanism unknown, but two main hypothesis
• Mechanical vs. Biochemical
• MECHANICAL – Fat globules from disrupted bone
marrow or adipose tissue are forced into torn venules
in areas of trauma.
• BIOCHEMICAL – Hormonal changes caused by trauma
and/or sepsis induce systemic release of free fatty
acids (FFA) as chylomicrons which cause the systemic
FES.
MECHANICAL HYPOTHESIS-
 – Fractures of marrow-containing bone (Femur,
Pelvis) have the highest incidence of FES and
cause the largest volume of fat emboli, because the
disrupted venules in the marrow remain tethered open
by their osseous attachments.
 – The marrow contents enter the venous circulation
with little difficulty.
CONT..
This theory is supported by research on Orthopaedic
long bone (IM reaming) and spinal surgeries which
cause fat globules to enter the blood circulation
when vigorous reaming/fixation is done.
 Increased Pressure + Volume Extravasation
 Measuring fat globules pre and post reaming
shows significant difference in concentration
CONT..
 Fat droplets are deposited in the pulmonary capillary
beds and travel through arteriovenous shunts to the
brain. Systems affected include LUNG, BRAIN and
CIRCULATION.
 Microvascular lodging of droplets produces local
ischemia and inflammation, with concomitant release
of inflammatory mediators, platelet aggregation, and
vasoactive amines
BIOCHEMICAL :
 FES is dependent upon degradation of the embolized fat
into free fatty acids.
 Neutral fat does not cause an acute lung injury, it is
hydrolyzed over the course of hours to several products,
including FFA, which cause ARDS in animal models.
 CRP (acute phase reactant), which is elevated in trauma
patients, appears to be responsible in lipid agglutination
(FES) for both traumatic and non- traumatic FES.
CONT..
 The process of Neutral fat cells -> FFA ->
Agglutination with CRP may explain the time
sequence of clinical findings in FES.
 Onset of symptoms may coincide with
Agglutination.
 This theory is animal model based and
circumstantial at best.
 Diagnosis is made CLINICALLY NOT
CHEMICALLY. It does not matter how much
fat globules are in your circulation, it just matters if
you have their side effects.
 FES typically manifests 24 to 72 hours after the
initial insult. Rarely <12 hrs or >72 hrs.
TRIAD OF FES
 Hypoxemia
 Neurological abnormalities
 Petechial rash
EARLY SIGNS
 Dyspnea
 Tachypnea
 hypoxemia
PULMONARY:
 Hypoxia, rales, pleural friction rub
 Breath sounds: Loud harsh, Crepts & wheeze
 ARDS may develop(fat emboli obstructs lung vessel
(20microns) platelets and fibrin adhere.)
 ½ of pts with FES require mechanical ventilation (Bulger,
Archives of Surgery 1997; 132: 435-9)
 CXR usually normal early on, later may show
‘snowstorm’ pattern- diffuse bilateral infiltrates
 CT chest: ground glass opacification with interlobular
septal thickening
Fat embolism
NEUROLOGICAL FINDINGS:
 Usually occur after respiratory symptoms.
 Incidence 80% patients with FES
 Minor global dysfunction most common, but ranges from
mild delirium to coma.
 Seizures/focal deficits not common but can occur
 Transient and reversible in most cases
 CT Head: general edema, usually nonspecific
 MRI brain: Low density on T1, and high intensity T2
signal, correlates to degree of impairment
RASH:
 Petechial
 Usually on conjuntiva , neck, axillae
 Results from occlusion of dermal capillaries by fat
globules and then extravasations of RBC
 Fleeting & last short.Resolves in 5-7 days
 PATHOGNOMONIC, but only present in 20-50% of
patients
Fat embolism
Fat embolism
OTHER FINDINGS
 Retinopathy (exudates, cotton wool spots, hemorrhage)
 Lipiduria
 Fever (to 39-40ºC)
 DIC
 Myocardial depression (prominent S, T depression, RBBB,
arrythmia)
 Thrombocytopenia/Anemia
 Hypocalcemia
DIAGNOSIS
 FES is CLINICAL diagnosis, not biochemical.
 A high degree of suspicion is needed to make diagnosis
.
-Common misconception that the presence of fat
globules, either in sputum, urine, or a wedged PA
catheter, is necessary to confirm the diagnosis of FES
In 50% of fracture patients, fat globules was
demonstrated in the serum, without symptoms of FES.
HOWEVER
 Growing literature on the use of bronchoscopy with
bronchoalveolar lavage to detect fat droplets in alveolar
macrophages as a means to diagnose fat embolism.
Sensitivity and specificity are unknown, being studied in
Trauma patients
 FES = 1 major + 4 minor + fat microglobulinemia
 Still widely used today
 FES = femur fracture ± tibia fracture + 1 feature
 Based on respiratory parameters
3 TYPES- In 1962
 SUBCLINICAL FES
 NON FULMINANT FES
 FULMINANT FES
SUBCLINICAL FES:
 Around 3 days post trauma
 Probably occurs in almost all long bone
fractures of the lower extremity and fractures of
the pelvis
 Characterised by decreased PaO2, decreased
Hb% and decreased platelets. No clinical signs
and symptoms of respiratory insufficiency.
NONFULMINANT FES:
- Any time ,upto 6 days post trauma
-Clinical signs and symptoms are clearly evident.
 Petechiae, tachycardia, respiratory failure, and signs of CNS
embolism.
 Thrombocytopaenia, anaemia, and coagulation
abnormalities can be found, as can pulmonary alveolar and
interstitial opacities on chest x ray
 There is no definitive test for this version of the
syndrome, as most of the changes described can
occur as a result of trauma as well as a result of fat
embolism, the diagnosis remains a clinical one,
and the significance is uncertain
FULMINANT FES:
 Occurs very suddenly and rapidly after injury, and
progresses very quickly, often resulting in death within a
few hours of the initial trauma.
 Clinical features are acute respiratory failure, acute
cor pulmonale and embolic neurological changes.
 These occur shortly after injury and often result in the
death of the patient.
 Pats. with multiple fractures are particularly
susceptible to this form of the syndrome, which,
although it is relatively rare, is of immense clinical
significance because of its high mortality.
Fat embolism
TREATMENT IS LARGELY SUPPORTIVE
 Constant Positive Airway pressure(CPAP)
 Mechanical Ventilation
 Antibiotics
 Nutritional support
 Corticosteroids
 Heparins
Have all been used
INITIAL TREATMENT
 Adequate airway
 Start IV line – correct fluid deficit
 Basic investigation – including baseline chest X-ray
and ABG assay (v. imp).
 Nasogastric tube – should be inserted in patient
with severe trauma and gastric contents suctioned
to prevent aspiration and ARDS
MONITORING
 TPR, BP
 I/O chart – maintain output 50-100cc/hr
 CVP – to correct fluid deficit
 If overload  pulmn. Edema (4-8cm H2O)
 Pulmonary haemodynamics– PCWP for accurate mean
of deficit correction (5-12mm of Hg)
 Arterial blood gas monitoring
SPECIFIC DRUG THERAPY:
 Many drugs have tried, most without demonstrable
benefit in established ARDS except Corticosteroids
but with some prophylactic benefit.
Drugs which may be tried in Fat embolism associated
ARDS are:
 1.Ethanol : Lipase inhibitor, low incidence when level
>20mg.
 2.Heparin :  PL aggregation useful in DIC assoc
ARDS also.Controversial in trials.10000-15000 iu stat &
10000 iu 4-6hly with PTT at 1.5-2.5 INR.
 3.Hypertonic glucose: block post traumatic
mobilization of FFA – may improve oxygenation.
 4.Corticosteroids – stabilize cell member, PMN
adhesion, prevent surfactant reduction, protect
capillary endothelium, compliment activation and
minimize transudation.
CORTICOSTEROIDS –
Value in ARDS of Fat embolism, aspiration,
sepsis, shock and cerebral edema.
Helpful in late stage in recovering patients in
reducing fibrotic change.
Improve and preserve arterial oxygenation and
stimulate proliferation and maturation of Type II
pneumocyte.
CORTICOSTEROIDS -
Prophylactic dose 10mg/Kg Q8H
Or
80mg/kg bolus
Or
1-2gm IV over 24 hrs. & maintain for 48-96 hrs by
gradual reduction
ATLS Protocol :
 1. Early immobilization of fracture and early definitive
reduction (open or closed).
 2. Maintain intravascular volume to maintain
cardiovascular stability (hypovolemic shock
resuscitation), may use colloids (albumin) as it can
expand fluid and bind FFA.
 3. Mechanical ventilation with PEEP
 4. IV Ethanol has been used in Russia, Europe and
some American centres to decrease rate of FES.
J Bone Joint Surg Am. 1977 Oct;59(7):878-80
 “A raised level of alcohol in the blood was
associated with a lower incidence of fat embolism” all
other variables controlled.
- Other studies
- Can J Surg. 1970 Jan;13(1):41-9
- Br Med J. 1978 May 13;1(6122):1232-4
ROLE OF FRACTURE STABILIZATION
 Highly debated issue
 - Accumulated evidence over past decade support
early fixation within 24 hours of injury.
 Early IF – decompress # hematoma as ongoing
source of fat emboli and retained necrotic debris,
eliminate pain and physiologic stress with continued
# motion, optimize pulmn function, contributes to
reduced ventilatory dependence and improve
survival.
 But transient increasing pulmn Ar pressure and
worsening pulmn gas exchange observed during
reaming of medullary canal. So undreamed nailing
is suggested for femoral fixation in multiple #
patients.
PROGNOSIS
 Mild -undetected
 Mod -low mortality
 Severe -fatal unless if treatement
instituted early. Survivors have pulmonary sequele.
Fat embolism

More Related Content

What's hot (20)

Damage control orthopaedic surgery
Damage control orthopaedic surgeryDamage control orthopaedic surgery
Damage control orthopaedic surgery
 
Compartment syndrome
Compartment syndromeCompartment syndrome
Compartment syndrome
 
Principles of fractures
Principles of fracturesPrinciples of fractures
Principles of fractures
 
Chronic osteomyelitis
Chronic  osteomyelitisChronic  osteomyelitis
Chronic osteomyelitis
 
Open Fracture
Open FractureOpen Fracture
Open Fracture
 
Advanced trauma life support (atls)
Advanced trauma life support (atls)Advanced trauma life support (atls)
Advanced trauma life support (atls)
 
Open Fractures Classification and Management.
Open Fractures Classification and Management.Open Fractures Classification and Management.
Open Fractures Classification and Management.
 
Fat embolism
Fat embolismFat embolism
Fat embolism
 
Compartment syndrome
Compartment syndromeCompartment syndrome
Compartment syndrome
 
Hip dislocation
Hip dislocationHip dislocation
Hip dislocation
 
NECROTIZING FASCITIS
NECROTIZING FASCITISNECROTIZING FASCITIS
NECROTIZING FASCITIS
 
Tuberculosis of joint
Tuberculosis of jointTuberculosis of joint
Tuberculosis of joint
 
Tb spine
Tb spineTb spine
Tb spine
 
Colles fracture
Colles fractureColles fracture
Colles fracture
 
POLYTRAUMA AND DAMAGE CONTROL ORTHOPAEDICS
POLYTRAUMA AND DAMAGE CONTROL ORTHOPAEDICSPOLYTRAUMA AND DAMAGE CONTROL ORTHOPAEDICS
POLYTRAUMA AND DAMAGE CONTROL ORTHOPAEDICS
 
Pelvic fractures
Pelvic fracturesPelvic fractures
Pelvic fractures
 
Galeazzi fracture dislocation
Galeazzi fracture  dislocationGaleazzi fracture  dislocation
Galeazzi fracture dislocation
 
Osteochondroma (dr. mahesh)
Osteochondroma (dr. mahesh)Osteochondroma (dr. mahesh)
Osteochondroma (dr. mahesh)
 
Fat embolism
Fat embolismFat embolism
Fat embolism
 
Lower limb amputation
Lower limb amputationLower limb amputation
Lower limb amputation
 

Similar to Fat embolism

Similar to Fat embolism (20)

Fat embolism syndrome
Fat embolism syndrome Fat embolism syndrome
Fat embolism syndrome
 
Fatembolism
FatembolismFatembolism
Fatembolism
 
Fatembolism
FatembolismFatembolism
Fatembolism
 
Fat Embolism Syndrome
Fat Embolism SyndromeFat Embolism Syndrome
Fat Embolism Syndrome
 
FAT EMBOLISM.pptx
FAT EMBOLISM.pptxFAT EMBOLISM.pptx
FAT EMBOLISM.pptx
 
Fat embolism DR. FARAN MAHMOOD
Fat embolism DR. FARAN MAHMOODFat embolism DR. FARAN MAHMOOD
Fat embolism DR. FARAN MAHMOOD
 
Fat emboli syndrome
Fat emboli syndromeFat emboli syndrome
Fat emboli syndrome
 
fat embolism syndrome orthopaedics slides
fat embolism syndrome orthopaedics slidesfat embolism syndrome orthopaedics slides
fat embolism syndrome orthopaedics slides
 
Fat embolism and Fat Embolism Syndrome
Fat embolism  and Fat Embolism SyndromeFat embolism  and Fat Embolism Syndrome
Fat embolism and Fat Embolism Syndrome
 
fat embolisation syndrome
fat embolisation syndromefat embolisation syndrome
fat embolisation syndrome
 
Fatembolism synfrome 2
Fatembolism synfrome 2Fatembolism synfrome 2
Fatembolism synfrome 2
 
Fat embolism syndrome
Fat embolism syndromeFat embolism syndrome
Fat embolism syndrome
 
Fat embolism syndrome biplav
Fat embolism syndrome biplavFat embolism syndrome biplav
Fat embolism syndrome biplav
 
Fat embolism syndrome
Fat embolism syndromeFat embolism syndrome
Fat embolism syndrome
 
Fat embolism
Fat embolismFat embolism
Fat embolism
 
Fes
FesFes
Fes
 
Fat embolism Syndrome
Fat embolism SyndromeFat embolism Syndrome
Fat embolism Syndrome
 
Polytrauma part 3 (FES)
Polytrauma part 3 (FES)Polytrauma part 3 (FES)
Polytrauma part 3 (FES)
 
Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)
 
Fat embolism
Fat embolismFat embolism
Fat embolism
 

Recently uploaded

Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
General_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_WellbeingGeneral_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_WellbeingAnonymous
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
concept of total quality management (TQM).
concept of total quality management (TQM).concept of total quality management (TQM).
concept of total quality management (TQM).kishan singh tomar
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Physiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid ArthritisPhysiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid ArthritisNilofarRasheed1
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)Mohamed Rizk Khodair
 
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxGood Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxLikeways
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 

Recently uploaded (20)

Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
General_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_WellbeingGeneral_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_Wellbeing
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
concept of total quality management (TQM).
concept of total quality management (TQM).concept of total quality management (TQM).
concept of total quality management (TQM).
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Physiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid ArthritisPhysiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid Arthritis
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)
 
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxGood Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 

Fat embolism

  • 1. By Dr. Jitendra Wadhwani PG ORTHOPAEDICS PGIMS, ROHTAK
  • 2.  Zenker, a pathologist,1st identified fat embolism syndrome at autopsy 1862.  First diagnosed in 1873 by Dr Von Bergmann  1879 Fenger and Salisbury published description of FES
  • 3. Fat Emboli: Fat particles or droplets that travel through the circulation Fat Embolism: A process by which fat emboli passes into the bloodstream and lodges within a blood vessel. Fat Embolism Syndrome (FES): serious manifestation of fat embolism occasionally causes multi system dysfunction, the lungs are always involved and next is brain
  • 4. FAT EMBOLISM SYNDROME:  Clinical diagnosis, No specific laboratory test is diagnostic  Mostly associated with long bone and pelvic #, and more frequent in closed # then open #  Single long bone fracture 1-5% chance of developing FES, and increases with number of #  Onset is 24-72 hours from initial insult  Mortality: 5-15%
  • 8. CAUSES CONTD..  Non Trauma: agglutination of chylomicrons and VLDL by high levels of plasma CRP. – disease-related • Diabetes, acute pancreatitis, burns, SLE, sickle cell crisis – drug-related • parenteral lipid infusion – procedure-related • Orthopedic surgery, liposuction
  • 9. Exact mechanism unknown, but two main hypothesis • Mechanical vs. Biochemical • MECHANICAL – Fat globules from disrupted bone marrow or adipose tissue are forced into torn venules in areas of trauma. • BIOCHEMICAL – Hormonal changes caused by trauma and/or sepsis induce systemic release of free fatty acids (FFA) as chylomicrons which cause the systemic FES.
  • 10. MECHANICAL HYPOTHESIS-  – Fractures of marrow-containing bone (Femur, Pelvis) have the highest incidence of FES and cause the largest volume of fat emboli, because the disrupted venules in the marrow remain tethered open by their osseous attachments.  – The marrow contents enter the venous circulation with little difficulty.
  • 11. CONT.. This theory is supported by research on Orthopaedic long bone (IM reaming) and spinal surgeries which cause fat globules to enter the blood circulation when vigorous reaming/fixation is done.  Increased Pressure + Volume Extravasation  Measuring fat globules pre and post reaming shows significant difference in concentration
  • 12. CONT..  Fat droplets are deposited in the pulmonary capillary beds and travel through arteriovenous shunts to the brain. Systems affected include LUNG, BRAIN and CIRCULATION.  Microvascular lodging of droplets produces local ischemia and inflammation, with concomitant release of inflammatory mediators, platelet aggregation, and vasoactive amines
  • 13. BIOCHEMICAL :  FES is dependent upon degradation of the embolized fat into free fatty acids.  Neutral fat does not cause an acute lung injury, it is hydrolyzed over the course of hours to several products, including FFA, which cause ARDS in animal models.  CRP (acute phase reactant), which is elevated in trauma patients, appears to be responsible in lipid agglutination (FES) for both traumatic and non- traumatic FES.
  • 14. CONT..  The process of Neutral fat cells -> FFA -> Agglutination with CRP may explain the time sequence of clinical findings in FES.  Onset of symptoms may coincide with Agglutination.  This theory is animal model based and circumstantial at best.
  • 15.  Diagnosis is made CLINICALLY NOT CHEMICALLY. It does not matter how much fat globules are in your circulation, it just matters if you have their side effects.  FES typically manifests 24 to 72 hours after the initial insult. Rarely <12 hrs or >72 hrs.
  • 16. TRIAD OF FES  Hypoxemia  Neurological abnormalities  Petechial rash
  • 17. EARLY SIGNS  Dyspnea  Tachypnea  hypoxemia
  • 18. PULMONARY:  Hypoxia, rales, pleural friction rub  Breath sounds: Loud harsh, Crepts & wheeze  ARDS may develop(fat emboli obstructs lung vessel (20microns) platelets and fibrin adhere.)  ½ of pts with FES require mechanical ventilation (Bulger, Archives of Surgery 1997; 132: 435-9)  CXR usually normal early on, later may show ‘snowstorm’ pattern- diffuse bilateral infiltrates  CT chest: ground glass opacification with interlobular septal thickening
  • 20. NEUROLOGICAL FINDINGS:  Usually occur after respiratory symptoms.  Incidence 80% patients with FES  Minor global dysfunction most common, but ranges from mild delirium to coma.  Seizures/focal deficits not common but can occur  Transient and reversible in most cases  CT Head: general edema, usually nonspecific  MRI brain: Low density on T1, and high intensity T2 signal, correlates to degree of impairment
  • 21. RASH:  Petechial  Usually on conjuntiva , neck, axillae  Results from occlusion of dermal capillaries by fat globules and then extravasations of RBC  Fleeting & last short.Resolves in 5-7 days  PATHOGNOMONIC, but only present in 20-50% of patients
  • 24. OTHER FINDINGS  Retinopathy (exudates, cotton wool spots, hemorrhage)  Lipiduria  Fever (to 39-40ºC)  DIC  Myocardial depression (prominent S, T depression, RBBB, arrythmia)  Thrombocytopenia/Anemia  Hypocalcemia
  • 25. DIAGNOSIS  FES is CLINICAL diagnosis, not biochemical.  A high degree of suspicion is needed to make diagnosis . -Common misconception that the presence of fat globules, either in sputum, urine, or a wedged PA catheter, is necessary to confirm the diagnosis of FES In 50% of fracture patients, fat globules was demonstrated in the serum, without symptoms of FES. HOWEVER  Growing literature on the use of bronchoscopy with bronchoalveolar lavage to detect fat droplets in alveolar macrophages as a means to diagnose fat embolism. Sensitivity and specificity are unknown, being studied in Trauma patients
  • 26.  FES = 1 major + 4 minor + fat microglobulinemia  Still widely used today
  • 27.  FES = femur fracture ± tibia fracture + 1 feature  Based on respiratory parameters
  • 28. 3 TYPES- In 1962  SUBCLINICAL FES  NON FULMINANT FES  FULMINANT FES
  • 29. SUBCLINICAL FES:  Around 3 days post trauma  Probably occurs in almost all long bone fractures of the lower extremity and fractures of the pelvis  Characterised by decreased PaO2, decreased Hb% and decreased platelets. No clinical signs and symptoms of respiratory insufficiency.
  • 30. NONFULMINANT FES: - Any time ,upto 6 days post trauma -Clinical signs and symptoms are clearly evident.  Petechiae, tachycardia, respiratory failure, and signs of CNS embolism.  Thrombocytopaenia, anaemia, and coagulation abnormalities can be found, as can pulmonary alveolar and interstitial opacities on chest x ray
  • 31.  There is no definitive test for this version of the syndrome, as most of the changes described can occur as a result of trauma as well as a result of fat embolism, the diagnosis remains a clinical one, and the significance is uncertain
  • 32. FULMINANT FES:  Occurs very suddenly and rapidly after injury, and progresses very quickly, often resulting in death within a few hours of the initial trauma.  Clinical features are acute respiratory failure, acute cor pulmonale and embolic neurological changes.  These occur shortly after injury and often result in the death of the patient.
  • 33.  Pats. with multiple fractures are particularly susceptible to this form of the syndrome, which, although it is relatively rare, is of immense clinical significance because of its high mortality.
  • 35. TREATMENT IS LARGELY SUPPORTIVE  Constant Positive Airway pressure(CPAP)  Mechanical Ventilation  Antibiotics  Nutritional support  Corticosteroids  Heparins Have all been used
  • 36. INITIAL TREATMENT  Adequate airway  Start IV line – correct fluid deficit  Basic investigation – including baseline chest X-ray and ABG assay (v. imp).  Nasogastric tube – should be inserted in patient with severe trauma and gastric contents suctioned to prevent aspiration and ARDS
  • 37. MONITORING  TPR, BP  I/O chart – maintain output 50-100cc/hr  CVP – to correct fluid deficit  If overload  pulmn. Edema (4-8cm H2O)  Pulmonary haemodynamics– PCWP for accurate mean of deficit correction (5-12mm of Hg)  Arterial blood gas monitoring
  • 38. SPECIFIC DRUG THERAPY:  Many drugs have tried, most without demonstrable benefit in established ARDS except Corticosteroids but with some prophylactic benefit.
  • 39. Drugs which may be tried in Fat embolism associated ARDS are:  1.Ethanol : Lipase inhibitor, low incidence when level >20mg.  2.Heparin :  PL aggregation useful in DIC assoc ARDS also.Controversial in trials.10000-15000 iu stat & 10000 iu 4-6hly with PTT at 1.5-2.5 INR.  3.Hypertonic glucose: block post traumatic mobilization of FFA – may improve oxygenation.
  • 40.  4.Corticosteroids – stabilize cell member, PMN adhesion, prevent surfactant reduction, protect capillary endothelium, compliment activation and minimize transudation.
  • 41. CORTICOSTEROIDS – Value in ARDS of Fat embolism, aspiration, sepsis, shock and cerebral edema. Helpful in late stage in recovering patients in reducing fibrotic change. Improve and preserve arterial oxygenation and stimulate proliferation and maturation of Type II pneumocyte.
  • 42. CORTICOSTEROIDS - Prophylactic dose 10mg/Kg Q8H Or 80mg/kg bolus Or 1-2gm IV over 24 hrs. & maintain for 48-96 hrs by gradual reduction
  • 43. ATLS Protocol :  1. Early immobilization of fracture and early definitive reduction (open or closed).  2. Maintain intravascular volume to maintain cardiovascular stability (hypovolemic shock resuscitation), may use colloids (albumin) as it can expand fluid and bind FFA.  3. Mechanical ventilation with PEEP
  • 44.  4. IV Ethanol has been used in Russia, Europe and some American centres to decrease rate of FES. J Bone Joint Surg Am. 1977 Oct;59(7):878-80  “A raised level of alcohol in the blood was associated with a lower incidence of fat embolism” all other variables controlled. - Other studies - Can J Surg. 1970 Jan;13(1):41-9 - Br Med J. 1978 May 13;1(6122):1232-4
  • 45. ROLE OF FRACTURE STABILIZATION  Highly debated issue  - Accumulated evidence over past decade support early fixation within 24 hours of injury.
  • 46.  Early IF – decompress # hematoma as ongoing source of fat emboli and retained necrotic debris, eliminate pain and physiologic stress with continued # motion, optimize pulmn function, contributes to reduced ventilatory dependence and improve survival.
  • 47.  But transient increasing pulmn Ar pressure and worsening pulmn gas exchange observed during reaming of medullary canal. So undreamed nailing is suggested for femoral fixation in multiple # patients.
  • 48. PROGNOSIS  Mild -undetected  Mod -low mortality  Severe -fatal unless if treatement instituted early. Survivors have pulmonary sequele.